At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub
FDA Law
JULY 17, 2024
Importantly, the Hub is intended to establish a new model within FDA, which leverages cross-Agency expertise in providing guidance and conducting reviews for products for rare disease populations. those reviewed by the CDER Division of Rare Diseases and Medical Genetics). By Sarah Wicks & James E. Valentine & Frank J.
105 
Let's personalize your content